SKF7™ is the standardized bio-extract of the Labisia pumila plant, also known as Kacip Fatimah, which is native to Malaysia. Since 2019, SKF7™ has been subjected to rigorous pre-clinical trials to study its efficacy in curtailing obesity and its associated diseases.
SKF7™ is currently undergoing rigorous in-human clinical tests in Malaysia and Indonesia in order to be classified and marketed as a botanical drug. This same study has just been completed in India. The results of these tests are expected to be released in the first quarter of 2021. SKF7™ is the main ingredient in a weight loss aid marketed as Labeesity® in Singapore, Malaysia and Indonesia.
Pre-clinical research indicates the ingredient’s effectiveness in curtailing obesity, inhibiting visceral fat accumulation, normalizing blood glucose levels as well as reducing total cholesterol, triglyceride levels and waist circumference. Studies on its efficacy in treating diabetes, cancer and combating SARS-CoV-2 which causes Covid-19, are currently underway.